A Study to Test if TEV-48574 is Effective in Relieving Asthma

Study Title
A 16-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Proof-of-Concept Study to Evaluate the Efficacy and Safety of TEV-48574 in Adults With T2-low/Non-T2 Severe Uncontrolled Asthma
Teva Identifier
TV48574-AS-20031 | 2020-001927-15
ClinicalTrials.gov Identifier
NCT04545385
Study Status
Terminated
Trial Condition(s)
Asthma
Interventions
Drug: TEV-48574 | Drug: Placebo
EudraCT Number
2020-001927-15
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
respiratory-icon

Key Participation Requirements

Gender
Female, Male
Age group
Adult, Older Adult
Age Range
18 Years and older
Trial Duration
October 07, 2020 - January 17, 2022
Phase
Phase 2

Study Type

Interventional